Insilico Medicine (HKG:3696) will be added to the FTSE Global Equity Index Series following FTSE Russell's quarterly review, according to a Monday Hong Kong bourse filing.
The artificial intelligence drug discovery company will join the FTSE Global Small Cap Index, FTSE Global All Cap Index, and FTSE Global Total Cap Index, with the changes taking effect on June 22.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments